1.Mayfield, IL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31:995–1000.
2.Boyce, JM, Havill, NL, Otter, JA, et al.Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare Setting. Infect Control Hosp Epidemiol 2008;29:723–729.
3.Otter, JA, Cummins, M, Ahmad, F, van Tonder, C, Drabu, YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67:182–188.
4.Johnston, MD, Lawson, S, Otter, JA. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005;60:403–411.
5.French, GL, Otter, LA, Shannon, KP, Adams, NM, Watling, D, Parks, MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004;57:31–37.
6.Bates, CJ, Pearse, R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 2005;61:364–366.
7.Jeanes, A, Rao, G, Osman, M, Merrick, P. Eradication of persistent environmental MRSA. J Hosp Infect 2005;61:85–86.
8.Taneja, N, Biswal, M, Emmanuel, R, Singh, M, Sharma, M. Hydrogen peroxide fogging in an overcrowded tertiary care referral centre: some practical queries. J Hosp Infect 2005;60:85.
9.Lawrence, SI, Puzniak, LA, Shadel, BN, Gillespie, KN, Kollef, MH, Mundy, LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28:123–130.
10.Passaretti, CL, Otter, JA, Lipsett, P, et al.Adherence to Hydrogen Peroxide Vapor (HPV) decontamination reduces VRE acquisition in high-risk units. Paper presented at: 48th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America. October 10, 2008; Washington, DC (abstract K4124b).